Blue Cross and Blue Shield of Michigan (BCBSM) is now incentivizing physicians for participating in medication assisted treatment (MAT) services for patients with opioid use disorders (OUD). Buprenorphine and naltrexone are included in the MAT incentive. Physicians, nurse practitioners, and physician assistants who deliver MAT to patients with opioid use disorder count toward the requirements to earn the practice transformation funding.
Primary care and specialty practices will be eligible to receive a 5% value-based reimbursement (VBR) for delivering MAT services. The PCP increase starts with the 2020 VBR cycle and specialty providers are eligible starting with the 2021 VBR. Patient-centered medical home (PCMH) designated primary care offices are also eligible to receive additional practice transformation funding dollars for services rendered to patients with opioid use disorders, within a specified time frame. The Physician Alliance will collect required information from the practice and report to BCBSM so that eligible practices may receive the incentives.
Physicians must receive a waiver to prescribe buprenorphine-containing medication.
Click here to apply
for a practitioner waiver.
edication assisted treatment.